NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Findings from Menoufiya University, Medical Department broaden understanding of breast cancer



January 8th, 2009

According to a study from Egypt, "This prospective study was designed to assess the utility of the dual time point imaging technique using 2-[F-18]-fluoro-2-deoxy-D- glucose (FDG) positron-emission tomography/computed tomography (PET/CT) to detect primary breast cancer and to determine whether it is useful for the detection of small and non-invasive cancers, as well as cancers in dense breast tissue. One hundred and eleven patients with newly diagnosed breast cancer underwent two sequential PET/CT examinations (dual time point imaging) for preoperative staging."

"The maximum standardized uptake value (SUVmax) of FDG was measured from both time points. The percentage...


Source: Women's Health Weekly (2009-01-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login